Carian E. Boorsma
- Co-authors
- Barbro N. MelgertChristina DraijerMachteld N. HylkemaPatricia RobbeKlaas PoelstraCatharina Reker‐SmitEduard PostPeter Heukels
- Topics
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers)IL-33, ST2, and ILC Pathways (4 papers)Asthma and respiratory diseases (4 papers)
- Journals
- American Journal of Respiratory and Critical Care MedicineScientific ReportsJournal of Leukocyte Biology
- Partner nations
- NetherlandsUnited StatesUnited Kingdom
In The Last Decade
Carian E. Boorsma
14 papers receiving 416 citations
Peers
Comparison fields: 5 of 75
- Immunology 184
- Pulmonary and Respiratory Medicine 176
- Physiology 118
- Molecular Biology 105
- Oncology 37
Countries citing papers authored by Carian E. Boorsma
This map shows the geographic impact of Carian E. Boorsma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carian E. Boorsma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carian E. Boorsma more than expected).
Fields of papers citing papers by Carian E. Boorsma
This network shows the impact of papers produced by Carian E. Boorsma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carian E. Boorsma. The network helps show where Carian E. Boorsma may publish in the future.
Co-authorship network of co-authors of Carian E. Boorsma
This figure shows the co-authorship network connecting the top 25 collaborators of Carian E. Boorsma. A scholar is included among the top collaborators of Carian E. Boorsma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carian E. Boorsma. Carian E. Boorsma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 15 | |
| 3 | 39 | |
| 4 | 50 | |
| 5 | 41 | |
| 6 | 20 | |
| 7 | PGE2-treated macrophages inhibit development of allergic lung inflammation in mice | 2 |
| 8 | 37 | |
| 9 | 4 | |
| 10 | 24 | |
| 11 | 15 | |
| 12 | A Possible Role For The Rank/rankl/opg Axis In Pulmonary Fibrosis | 2 |
| 13 | 66 | |
| 14 | 109 |
About Carian E. Boorsma
Carian E. Boorsma is a scholar working on Immunology, Pulmonary and Respiratory Medicine and Physiology, having authored 14 papers that have together received 426 indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), IL-33, ST2, and ILC Pathways (4 papers) and Asthma and respiratory diseases (4 papers). The work is most often cited by research in Immunology (184 citations), Pulmonary and Respiratory Medicine (176 citations) and Physiology (118 citations). Carian E. Boorsma has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Barbro N. Melgert, Christina Draijer, Machteld N. Hylkema, Patricia Robbe, Klaas Poelstra, Catharina Reker‐Smit, Eduard Post, Peter Heukels, Menno van Nimwegen and Bernt van den Blink. Their work appears in journals such as American Journal of Respiratory and Critical Care Medicine, Scientific Reports and Journal of Leukocyte Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.